| Cvs Pharmacy #16344 | |
| 11253 Pines Blvd, Pembroke Pines, Florida 33026 | |
| (954) 435-9363 |
| Name | Cvs Pharmacy #16344 |
|---|---|
| Organization Name | Holiday Cvs Llc |
| Location | 11253 Pines Blvd, Pembroke Pines, Florida 33026 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (954) 435-9363 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
A new study in the March 1 issue of the journal Sleep indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week.
PAREXEL International Corporation, the world's leading innovator of biopharmaceutical services, today announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, effective May 7, 2018. Ms. Howell most recently served as Executive Vice President at AmerisourceBergen and will be responsible for leading PAREXEL's commercial strategy, including global sales, customer service and sales operations.
Researchers from Boston University's School of Medicine and College of Arts and Sciences found that among HIV-infected Russian drinkers, depressive symptom severity alone was not significantly associated with lower rates of antiretroviral therapy initiation. However, when examining cognitive symptoms of depression, results showed that high levels of depressive symptoms may be associated with delayed ART initiation.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 4 days ago
| NPI Number | 1093737637 |
| Organization Name | HOLIDAY CVS LLC |
| Doing Business As | CVS PHARMACY #16344 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 11253 Pines Blvd, Pembroke Pines, FL 33026 |
| Phone Number | 954-435-9363 |
News Archive
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
A new study in the March 1 issue of the journal Sleep indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week.
PAREXEL International Corporation, the world's leading innovator of biopharmaceutical services, today announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, effective May 7, 2018. Ms. Howell most recently served as Executive Vice President at AmerisourceBergen and will be responsible for leading PAREXEL's commercial strategy, including global sales, customer service and sales operations.
Researchers from Boston University's School of Medicine and College of Arts and Sciences found that among HIV-infected Russian drinkers, depressive symptom severity alone was not significantly associated with lower rates of antiretroviral therapy initiation. However, when examining cognitive symptoms of depression, results showed that high levels of depressive symptoms may be associated with delayed ART initiation.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 4 days ago
News Archive
Using skin cells from young patients who have a severe genetic heart defect, Stanford University School of Medicine scientists have generated beating heart cells that carry the same genetic mutation. The newly created human heart cells - cardiomyocytes - allowed the researchers for the first time to examine and characterize the disorder at the cellular level.
A new study in the March 1 issue of the journal Sleep indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week.
PAREXEL International Corporation, the world's leading innovator of biopharmaceutical services, today announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, effective May 7, 2018. Ms. Howell most recently served as Executive Vice President at AmerisourceBergen and will be responsible for leading PAREXEL's commercial strategy, including global sales, customer service and sales operations.
Researchers from Boston University's School of Medicine and College of Arts and Sciences found that among HIV-infected Russian drinkers, depressive symptom severity alone was not significantly associated with lower rates of antiretroviral therapy initiation. However, when examining cognitive symptoms of depression, results showed that high levels of depressive symptoms may be associated with delayed ART initiation.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that tumor necrosis factor (TNF)-alpha inhibitors will continue to dominate first- and second-line biologic therapy for the treatment of rheumatoid arthritis in the United States through 2011, but the more established branded drugs such as, Centocor Ortho Biotech's Remicade, Abbott's Humira and Amgen/Wyeth's Enbrel, in this class will face competition from newer entrants.
› Verified 4 days ago
Cvs Pharmacy # 03607 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11100 Pines Blvd, Pembroke Pines, Florida 33026 Phone: (954) 432-6804 | |
Cvs Pharmacy # 04659 Type: Pharmacy Location: 17201 Pines Blvd, Pembroke Pines, Florida 33029 Phone: (954) 431-8830 | |
Cvs Pharmacy #02849 Type: Pharmacy Location: 1698 S Palm Ave, Pembroke Pines, Florida 33025 Phone: (954) 885-8547 | |
Cvs Pharmacy #02828 Type: Pharmacy Location: 1701 N University Dr, Pembroke Pines, Florida 33024 Phone: (954) 322-7502 | |
Cvs Pharmacy #01147 Type: Pharmacy Location: 70 N University Dr, Pembroke Pines, Florida 33024 Phone: (954) 432-5510 |